Company news

Sophia Genetics Sa (NASDAQ:SOPH) news

Sophia Genetics Sa news releases on 6ix. Latest, Sep 12, 2024: SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

View Sophia Genetics Sa →

Press releases — page 2

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

September 11, 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

September 11, 2024

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

September 9, 2024

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

September 4, 2024

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

September 3, 2024

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

August 27, 2024

SOPHiA DDM™ Platform Certified Under IVDR

August 13, 2024

SOPHiA GENETICS Reports Second Quarter 2024 Results

August 5, 2024

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

July 28, 2024

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

July 23, 2024

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

July 22, 2024

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

July 3, 2024

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

June 23, 2024

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

June 23, 2024

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

June 12, 2024

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

May 29, 2024

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

May 28, 2024

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

May 19, 2024

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

May 15, 2024

SOPHiA GENETICS Reports First Quarter 2024 Results

May 6, 2024

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

April 29, 2024

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

April 22, 2024

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

April 22, 2024

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

April 16, 2024

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

April 3, 2024

Laboratorio Barnafi-Krause is Live on SOPHiA DDM™

April 1, 2024

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

March 19, 2024

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

March 14, 2024

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference

March 6, 2024

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

March 4, 2024

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

February 21, 2024

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024

February 19, 2024

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

February 6, 2024

SOPHiA GENETICS Supports Genetic Testing in Brazil

January 24, 2024

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

January 17, 2024

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

January 13, 2024

SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference

January 9, 2024

Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data Analytics

January 7, 2024

Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid Disorders

December 20, 2023

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

December 13, 2023

SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings

December 6, 2023

SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes

November 29, 2023

SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino

November 27, 2023

The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICS

November 16, 2023

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023

November 6, 2023

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

November 6, 2023

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023

October 23, 2023

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care

October 17, 2023

Shaare Zedek Medical Center Uses SOPHiA GENETICS to Advance Research of Myeloid Disorders

September 28, 2023

Laboratorio Curie Expands Relationship with SOPHiA GENETICS

September 12, 2023

← Newer · Older →